Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.

Background: Lung cancer is one of the main causes for cancer death. A reliable diagnosis and follow-up of patients is important support for a successful therapy. The diagnostic efficiency of a new marker Tumor M2-pyruvate kinase (Tumor M2-PK) is evaluated.